We serve Chemical Name:Benzamidine CAS:618-39-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Benzamidine
CAS.NO:618-39-3
Synonyms:Benzamidine;Benzenecarboximidamide;benzimidamide;Amidinobenzene;EINECS 210-546-3;MFCD00042826;phenyl-amidine;Benzamidinium chloride
Molecular Formula:C7H8N2
Molecular Weight:120.152
HS Code:
Physical and Chemical Properties:
Melting point:65-70ºC
Boiling point:208.5±23.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.570
PSA:49.87000
Exact Mass:120.068748
LogP:0.65
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Benzamidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzamidinium chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenecarboximidamide Use and application,EINECS 210-546-3 technical grade,usp/ep/jp grade.
Related News: Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA. Benzamidine manufacturer Retrogenix holds two Queen��s Awards for Enterprise, the UK��s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA. Benzamidine supplier At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities. Benzamidine vendor Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. Benzamidine factory China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.
